Medplus Health Services Limited - Asset Resilience Ratio

Latest as of March 2026: 10.54%

Medplus Health Services Limited (MEDPLUS) has an Asset Resilience Ratio of 10.54% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs4.15 Billion
≈ $44.83 Million USD Cash + Short-term Investments

Total Assets

Rs39.33 Billion
≈ $425.29 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2026)

This chart shows how Medplus Health Services Limited's Asset Resilience Ratio has changed over time. Check Medplus Health Services Limited strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Medplus Health Services Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see MEDPLUS stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs4.15 Billion 10.54%
Total Liquid Assets Rs4.15 Billion 10.54%

Asset Resilience Insights

  • Moderate Liquidity: Medplus Health Services Limited has 10.54% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

Medplus Health Services Limited Industry Peers by Asset Resilience Ratio

Compare Medplus Health Services Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Dashenlin Pharm Grp Co Ltd
SHG:603233
Pharmaceutical Retailers 0.80%
Raia Drogasil S.A
SA:RADL3
Pharmaceutical Retailers 0.38%
Empreendimentos Pague Menos S.A
SA:PGMN3
Pharmaceutical Retailers 0.00%
d1000 Varejo Farma Participações S.A
SA:DMVF3
Pharmaceutical Retailers 2.05%
High Tide Inc
V:HITI
Pharmaceutical Retailers 0.03%
Yifeng Pharmacy
SHG:603939
Pharmaceutical Retailers 19.16%
Laobaixing Pharmacy
SHG:603883
Pharmaceutical Retailers 0.01%
Yunnan Hongxiang Yixintang
SHE:002727
Pharmaceutical Retailers 4.78%

Annual Asset Resilience Ratio for Medplus Health Services Limited (2019–2026)

The table below shows the annual Asset Resilience Ratio data for Medplus Health Services Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2026-03-31 10.54% Rs4.15 Billion
≈ $44.83 Million
Rs39.33 Billion
≈ $425.29 Million
+0.01pp
2025-03-31 10.53% Rs3.54 Billion
≈ $38.26 Million
Rs33.60 Billion
≈ $363.38 Million
+8.07pp
2024-03-31 2.46% Rs738.26 Million
≈ $7.98 Million
Rs30.05 Billion
≈ $324.96 Million
+0.30pp
2023-03-31 2.16% Rs602.99 Million
≈ $6.52 Million
Rs27.97 Billion
≈ $302.45 Million
-22.37pp
2022-03-31 24.52% Rs6.36 Billion
≈ $68.79 Million
Rs25.94 Billion
≈ $280.54 Million
+21.82pp
2021-03-31 2.70% Rs423.16 Million
≈ $4.58 Million
Rs15.66 Billion
≈ $169.32 Million
+0.70pp
2020-03-31 2.00% Rs270.30 Million
≈ $2.92 Million
Rs13.49 Billion
≈ $145.86 Million
-0.59pp
2019-03-31 2.59% Rs248.24 Million
≈ $2.68 Million
Rs9.59 Billion
≈ $103.68 Million
--
pp = percentage points

About Medplus Health Services Limited

NSE:MEDPLUS India Pharmaceutical Retailers
Market Cap
$904.40 Million
Rs83.63 Billion INR
Market Cap Rank
#9229 Global
#465 in India
Share Price
Rs696.40
Change (1 day)
-1.21%
52-Week Range
Rs691.95 - Rs953.90
All Time High
Rs1290.00
About

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soap… Read more